Best Hospitals for Intra-Aortic Balloon Pump Insertion in Dubai, UAE

The Intra-Aortic Balloon Pump (IABP) is a temporary mechanical circulatory support device consisting of a polyethylene terephthalate (PET) balloon catheter, typically 25–50 mL in volume, positioned in the descending thoracic aorta just distal to the left subclavian artery. The device operates on the principle of counterpulsation — it inflates during diastole (triggered by the R-wave on continuous ECG) to augment diastolic pressure and coronary perfusion pressure, and deflates rapidly at the onset of systole to reduce left ventricular afterload and myocardial oxygen demand. The net physiological effect is an improvement in the myocardial oxygen supply-demand ratio, an increase in cardiac output of approximately 0.5–1.0 L/min, and a reduction in pulmonary capillary wedge pressure, making it indispensable in the management of acute left ventricular dysfunction.

• ELIGIBLE PATIENTS (Primary Indications):
• Cardiogenic shock secondary to acute myocardial infarction (AMI) with or without revascularization (PCI/CABG)
• Refractory unstable angina unresponsive to maximal medical therapy (nitrates, beta-blockers, antiplatelet agents, heparin)
• Acute decompensated heart failure with low cardiac output syndrome (cardiac index < 2.2 L/min/m²)
• High-risk percutaneous coronary intervention (PCI) — unprotected left main disease, severely reduced ejection fraction (EF < 35%), or last remaining conduit
• +23 more

IABP Insertion TECHNIQUES:

1. Standard Percutaneous Femoral Approach (Most Common):

The femoral artery is accessed under sterile conditions using the modified Seldinger technique, typically via the common femoral artery below the inguinal ligament. A 7–8 Fr introducer sheath is placed, and the pre-wrapped balloon catheter (sized to patient height: 25 mL for patients < 152 cm, 34 mL for 152–162 cm, 40 mL for 162–182 cm, 50 mL for > 182 cm) is advanced over a 0.025–0.030-inch guidewire under fluoroscopic guidance. Final balloon position is confirmed with the radiopaque tip 2–3 cm distal to the origin of the left subclavian artery (at the level of the carina on chest X-ray, approximately at the T4–T5 level). The procedure takes 15–30 minutes in experienced hands. Unsheathed (sheathless) balloon catheters are preferred in patients with marginal peripheral vasculature to minimize limb ischemia risk.

2. Axillary / Subclavian Artery Approach (Ambulatory IABP):

PHASE 1 — PRE-PROCEDURE ASSESSMENT AND STABILIZATION (Day 0–1):

• Emergency or elective admission to the Cardiac Care Unit (CCU) or Cardiac Catheterization Laboratory.
• Rapid hemodynamic assessment: vital signs, invasive arterial blood pressure monitoring, Swan-Ganz catheter placement (if indicated) to measure pulmonary capillary wedge pressure, cardiac output, and systemic vascular resistance.
• Urgent echocardiography (TTE/TEE) to define LV function, identify mechanical complications, and assess aortic valve competence.
• Coronary angiography performed simultaneously in AMI-cardiogenic shock patients to identify culprit vessel for revascularization.
• Blood work: CBC, coagulation profile, metabolic panel, troponin, BNP, lactate, ABG.
• Bilateral lower limb pulse assessment; Doppler ultrasound of femoral arteries if peripheral vascular disease is suspected.
• Informed consent obtained; patient and family counseled on procedure, risks, expected duration of support, and potential escalation therapies.
• Anticoagulation initiated: unfractionated heparin infusion (target aPTT 50–70 seconds) to prevent thrombus formation on the balloon.

PHASE 2 — IABP INSERTION PROCEDURE (Day 1; Duration: 15–45 minutes):